Search research articles
Contact Us
Filters
Showing results (31-40 of 126) with videos related to
Page
of 13
Sort By:
Drug Discovery Today
|
September 1, 2015
Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials
David M Hyman, David B Solit, Maria E Arcila, et al.
Journal of Geriatric Oncology
|
January 30, 2014
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
Linda T Vahdat, Eduard Vrdoljak, Henry Gómez, et al.
Breast Cancer Research and Treatment
|
April 13, 2013
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer
Shanu Modi, Cristina Saura, Charles Henderson, et al.
Cancer Discovery
|
September 9, 2016
Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer
Xiuning Le, Rajee Antony, Pedram Razavi, et al.
Investigational New Drugs
|
September 8, 2010
A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors
Eduardo Vilar, Viktor Grünwald, Patrick Schöffski, et al.
Cancer Cell
|
February 13, 2007
High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna, Rachel S Darken, Federico Rojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer
Giulia Bianchi, John Albanell, Wolfgang Eiermann, et al.
The Lancet. Oncology
|
December 15, 2016
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study
Stephen J Luen, Roberto Salgado, Stephen Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2016
Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors
Adriana Soler, Ana M Figueiredo, Pau Castel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
James A Bonner, Jordi Giralt, Paul M Harari, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 126) with videos related to
Sort By:
Page
of 13
Drug Discovery Today
|
September 1, 2015
Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials
David M Hyman, David B Solit, Maria E Arcila, et al.
Journal of Geriatric Oncology
|
January 30, 2014
Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer
Linda T Vahdat, Eduard Vrdoljak, Henry Gómez, et al.
Breast Cancer Research and Treatment
|
April 13, 2013
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancer
Shanu Modi, Cristina Saura, Charles Henderson, et al.
Cancer Discovery
|
September 9, 2016
Systematic Functional Characterization of Resistance to PI3K Inhibition in Breast Cancer
Xiuning Le, Rajee Antony, Pedram Razavi, et al.
Investigational New Drugs
|
September 8, 2010
A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors
Eduardo Vilar, Viktor Grünwald, Patrick Schöffski, et al.
Cancer Cell
|
February 13, 2007
High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna, Rachel S Darken, Federico Rojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2003
Pilot trial of trastuzumab starting with or after the doxorubicin component of a doxorubicin plus paclitaxel regimen for women with HER2-positive advanced breast cancer
Giulia Bianchi, John Albanell, Wolfgang Eiermann, et al.
The Lancet. Oncology
|
December 15, 2016
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study
Stephen J Luen, Roberto Salgado, Stephen Fox, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 27, 2016
Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors
Adriana Soler, Ana M Figueiredo, Pau Castel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 21, 2016
Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial
James A Bonner, Jordi Giralt, Paul M Harari, et al.
Page
of 13